Wohl & Fruchter LLP

Call Us 866-833-6245

  • About
  • Attorneys
  • Practice Areas
  • Cases
  • Results
  • News
  • Contact
  1. Home
  2. Cases
  3. MeridianLink

MeridianLink

We are investigating the fairness of the proposed sale of MeridianLink, Inc. (NYSE: MLNK) (“MeridianLink”) to Centerbridge Partners (“Centerbridge”) for $20.00 per share in cash.

The sale price is well below the 52-week high of $25.33 per share, and the price target of $24.00 per share of at least one Wall Street analyst, thus suggesting an opportunistic purchase by Centerbridge.

If you remain a MeridianLink shareholder and have concerns about the proposed sale, you may contact our firm to discuss your legal rights at no charge by completing and submitting the form below.

Why is there an investigation?

On August 11, 2025, MeridianLink announced that it had agreed to be sold to Centerbridge for $20.00 per share in cash.

The sale price is well below the 52-week high of $25.33 per share, and the price target of $24.00 per share of at least one Wall Street analyst (Alexander Sklar of Raymond James), thus suggesting an opportunistic purchase by Centerbridge.

“We are investigating whether the MeridianLink Board of Directors acted in the best interests of MeridianLink shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the price agreed upon is fair to MeridianLink shareholders, as well as whether all material information regarding the transaction has been fully disclosed.”

Contact Us About This Case

"*" indicates required fields

If you lost money, enter $ amount, and hit "tab" to verify. If you have a gain, enter $0.
Please check box*
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.
Click to Contact Us About This Case

Attorney

Joshua Fruchter
845-290-6818
alerts@wohlfruchter.com

  • Legal
  • Privacy Policy
  • Sitemap
  • Contact

Attorney Advertising. Prior results do not guarantee a similar outcome.

© 2025 Wohl & Fruchter LLP